Cytokine release syndrome as an important differential diagnosis of severe skin toxicity with organ damage during switch from immunotherapy to targeted therapy in metastatic melanoma

Melanoma Res. 2019 Feb;29(1):107-108. doi: 10.1097/CMR.0000000000000544.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents, Immunological / adverse effects*
  • Cytokines / metabolism*
  • Diagnosis, Differential
  • Humans
  • Immune System Diseases / chemically induced
  • Immune System Diseases / diagnosis*
  • Immunotherapy / adverse effects*
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Molecular Targeted Therapy / adverse effects*
  • Prognosis
  • Skin Diseases / chemically induced
  • Skin Diseases / diagnosis*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / secondary
  • Syndrome

Substances

  • Antineoplastic Agents, Immunological
  • Cytokines